Sign In | Sign Up | Help | Invite    
Advanced Search Ask A Question Community Recent Changes
My:             Contributions   
Contributors
{for ul in pageInfo.page}
${ul.nickName}
{var al = toBreakWord(ul.adUrl,18)} {if ul.adSentence !=''}${ul.adSentence}
{/if} {if ul.adUrl !=''}${al}
{/if}
 
{/for}
Earn Free Advertising   +   Earn Money By Writing What You Know at WISTEME.COM
Question Discussion History

Edit
    Question ID:   9063         Current Version: 1
Question: What are some new approaches to radiation therapy?
Category: Diseases & Conditions > Cancer
Keywords: new approach, radiation therapy
Type: what
Rating:(0 ratings)    Views: 307    Discussions: 0   In Watch Lists: 1  

 
    Answer:
Hyperthermia, the use of heat, is being studied in conjunction with radiation therapy. Researchers have found that the combination of heat and radiation can increase the response rate of some tumors.

Researchers are also studying the use of radiolabeled antibodies to deliver doses of radiation directly to the cancer site (radioimmunotherapy). Antibodies are highly specific proteins that are made by the body in response to the presence of antigens (substances recognized as foreign by the immune system). Some tumor cells contain specific antigens that trigger the production of tumor-specific antibodies. Large quantities of these antibodies can be made in the laboratory and attached to radioactive substances (a process known as radiolabeling). Once injected into the body, the antibodies seek out cancer cells, which are destroyed by the radiation. This approach can minimize the risk of radiation damage to healthy cells.

The success of this technique depends on identifying appropriate radioactive substances and determining the safe and effective dose of radiation that can be delivered in this way. Two radioimmunotherapy treatments, ibritumomab tiuxetan (Zevalin®) and tositumomab and iodine 131 tositumomab (Bexxar®), have been approved for advanced adult non-Hodgkin lymphoma (NHL). Clinical trials of radioimmunotherapy are under way with a number of cancers, including leukemia, NHL, colorectal cancer, and cancers of the liver, lung, brain, prostate, thyroid, breast, ovary, and pancreas.

Scientific advances have led to the discovery of new targets that are being investigated to attract radioactive materials directly to cancer cells. Laboratory and clinical research is in progress using the new molecular therapeutic agents, such as gefitinib (Iressa®) and imatinib mesylate (Gleevec®), with radiation therapy.

Source: U.S. National Cancer Institute
Read more questions from WISTEME through
     Add to MSN Add to My AOL
 Rate this Question
   Add to Groups   Add to Watch Lists   Share Question
                          
 
    More Readings :
[QID:9004]    How does the doctor measure the dose of radiation in radiation therapy?  
[QID:9042]    What is radiation therapy treatment planning, and why is it important?  
[QID:9029]    Who plans and delivers the radiation treatment to the patient?  
[QID:9021]    What are the methods in use or being studied to improve external radiation therapy?  
[QID:9005]    What are the sources of energy for radiation therapy?  
[QID:8992]    Will radiation therapy make the patient radioactive?  
[QID:8991]    What is radiation therapy?  
[QID:8999]    What is the difference between external radiation therapy, internal radiation therapy (brachytherapy), and systemic radiation therapy? When are these types used?  
[QID:2122]    What are the treatments for kidney cancer?  
[QID:9028]    What are low-LET and high-LET radiation?  
     Question ID:  ${question.id}         Current Version:  ${question.version}

{for qh in questionHistory} {if qh.status == 'r'} {else} {/if} {/for}
Version Contributor Date (ET) Voting
${qh.version} ${qh.nickName} ${qh.date} Rejected
${qh.version} ${qh.nickName} ${qh.date} {if qh.status != 'c'} {if qh.status == 'a'} Approved {else} {if qh.rstatus == 'c'} On-going {else} Pending {/if} {/if} {else}   {/if}
Start a New Topic
ID Topics Replies Latest Post (ET)
{if dlist!=null} {for d in dlist} {/for}
${parseInt(d_index)+1} ${d.sentence} ${d.replyNum} ${d.lastestDate}
{else}
No discussion topic.
{/if}
Label Name:
 
Group Name:
 
 
{else}
     You have no group.
{/if}
Advertisements
{if advertisements.length > 0} {else} {/if}
{for ad in advertisements}
${ad.adTitle}
${ad.adSentence}
${ad.adUrl}
{/for}

Home | About Us | Terms of Use | Privacy Policy | Browse Questions | RSS Feed

Copyright ©2010 WISTEME LLC. All Rights Reserved.